PTPN22 and neoplasm: The 131I-labeled LyP-1-modified dendrimers were demonstrated to be a good probe for SPECT imaging, a selective therapeutic tool both in vitro in 4T1 cells and in vivo in the 4T1 subcutaneous tumor mice model.